
Last updated: 2026-09-08 13:26:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Nyxoah SA (NYXH) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.64, with a market capitalisation of $164.98M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.26 to $6.87. This page covers its latest market performance, valuation, price trends and company information.
$164.98M | |
$1.68 | |
$37.00 | |
$1.26 | |
-- | |
33.05K | |
432.21K | |
-- | |
$6.87 | |
$1.26 | |
-- | |
-- |
Nyxoah SA (NYXH) is trading at $1.75 in pre-market trading as of 2026-09-08 13:25:00, -- from the previous close of $0.00
Pre-market trading shows how investors are pricing NYXH before the regular session opens. The current pre-market price is -- the previous close, indicating positive early trading sentiment.
Over the past seven days, Nyxoah SA (NYXH) moved from $1.57 to $1.64, representing a gain of 4.20% ($0.07).
The stock traded between $1.49 and $1.83 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 1.29 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 6.7%
NYXH is currently trading at $1.64, placing it 6.7% of the way from its 52-week low of $1.26 to its 52-week high of $6.87. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
| Employees | 154 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Nyxoah SA (NYXH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.